跳至主要内容
临床试验/NCT04953195
NCT04953195Unknown4 期

Effect of Thyroid Replacement Therapy on Thyroid Structure in Patients With Subclinical Hypothyroidism

Beijing Chao Yang Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
30
试验地点
1
主要终点
Thyroid Stimulating Hormone changes

研究概览

简要总结

The purpose of this experiment is to compared the changes of thyroid function, anti-thyroid peroxidase antibody, anti-thyroglobulin antibody, thyroid magnetic resonance T1-mapping and various metabolic indexes from baseline to the end of treatment (after the thyroid function had been normal for more than three months)

详细描述

In patients with autoimmune thyroiditis with mild subclinical hypothyroidism, the study period will include a screening period of not more than 30 days, and a 12-week treatment period compared to baseline. At completion of treatment, Thyroid Stimulating Hormone(TSH), free thyroxine (FT4),free thyroxine (FT3) will be included. The changes of anti-thyroglobulin antibody, anti-thyroglobulin antibody, T1-mapping and metabolic indexes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women between the ages of 18 and 75;
  • Diagnostic criteria for mild subclinical hypothyroidism :TSH>10mIU/L, thyroxine and free thyroxine levels were normal
  • Positive thyroglobulin antibody and/or Thyroperoxidase antibody
  • No previous use of drugs affecting thyroid function

排除标准

  • The contraindications indicated in the Chinese instructions of the drug
  • Liver function impairment
  • Renal function impairment
  • Claustrophobia
  • Mental disorders

研究组 & 干预措施

levothyroxine sodium

Experimental

levothyroxine sodium

干预措施: Levothyroxine Sodium Tablets (Drug)

结局指标

主要结局

Thyroid Stimulating Hormone changes

时间窗: Thyroid Stimulating Hormone Changes from baseline and 12 weeks during follow-up

Thyroid Stimulating Hormone Changes from baseline and 12 weeks during follow-up

free thyroxine changes

时间窗: free thyroxine changes from baseline and 12 weeks during follow-up

free thyroxine changes from baseline and 12 weeks during follow-up

Free triiodothyronine changes

时间窗: Free triiodothyronine changes Changes from baseline and 12 weeks during follow-up

Free triiodothyronine changes Changes from baseline and 12 weeks during follow-up

T1-mapping values of Thyroid MRI

时间窗: T1-mapping values of Thyroid MRI Changes from baseline and 12 weeks during follow-up

T1-mapping values of Thyroid MRI Changes from baseline and 12 weeks during follow-up

次要结局

  • anti-thyroid peroxidase antibody changes(anti-thyroid peroxidase antibody changes from baseline and 12 weeks during follow-up)
  • anti-thyroglobulin antibody changes(anti-thyroglobulin antibody changes from baseline and 12 weeks during follow-up)

研究者

发起方
Beijing Chao Yang Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Guang Wang

Director of Endocrinology

Beijing Chao Yang Hospital

研究点 (1)

Loading locations...

相似试验